GENEVA, June 19 -- BIOLEGEND, INC. filed a patent application (US2025/054897) for “CONTROL CELL POPULATIONS FOR DETECTION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA”. With publication no. WO/2026/106937, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/569
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....